Liesbeth Reneman - Publications

Affiliations: 
Academic Medical Center Amsterdam, Amsterdam, Netherlands 

105 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Karel P, Van der Toorn A, Vanderschuren L, Guo C, Sadighi Alvandi M, Reneman L, Dijkhuizen R, Verheij MMM, Homberg JR. Ultrahigh-resolution MRI reveals structural brain differences in serotonin transporter knockout rats after sucrose and cocaine self-administration. Addiction Biology. PMID 30748070 DOI: 10.1111/adb.12722  0.76
2019 Lønning K, Putzky P, Sonke JJ, Reneman L, Caan MWA, Welling M. Recurrent inference machines for reconstructing heterogeneous MRI data. Medical Image Analysis. 53: 64-78. PMID 30703579 DOI: 10.1016/j.media.2019.01.005  0.8
2018 Schrantee A, Lucassen PJ, Booij J, Reneman L. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30082141 DOI: 10.1016/j.euroneuro.2018.07.099  1
2018 Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Kerst JM, Kirschbaum C, Reneman L, Schagen SB. Brain hyperconnectivity >10 years after cisplatin based chemotherapy for testicular cancer. Brain Connectivity. PMID 29999422 DOI: 10.1089/brain.2017.0569  0.96
2018 Kaag AM, Reneman L, Homberg J, van den Brink W, van Wingen GA. Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma. Frontiers in Psychiatry. 9: 70. PMID 29593581 DOI: 10.3389/fpsyt.2018.00070  0.96
2018 Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB, Kooij SJJ, Reneman L. ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. Neuroimage. Clinical. 17: 53-59. PMID 29527472 DOI: 10.1016/j.nicl.2017.09.026  1
2018 van Iersel L, Meijneke RWH, Schouten-van Meeteren AYN, Reneman L, de Win MM, van Trotsenburg ASP, Bisschop PH, Finken MJJ, Vandertop WP, van Furth WR, van Santen HM. The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort. Pediatric Blood & Cancer. PMID 29314661 DOI: 10.1002/pbc.26911  0.72
2018 Karel P, Almacellas-Barbanoj A, Prijn J, Kaag AM, Reneman L, Verheij MMM, Homberg JR. Appetitive to aversive counter-conditioning as intervention to reduce reinstatement of reward-seeking behavior: the role of the serotonin transporter. Addiction Biology. PMID 29292566 DOI: 10.1111/adb.12596  0.96
2017 Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Research. 269: 36-42. PMID 28938219 DOI: 10.1016/j.pscychresns.2017.09.009  1
2017 Schulte MHJ, Kaag AM, Wiers RW, Schmaal L, van den Brink W, Reneman L, Homberg JR, van Wingen GA, Goudriaan AE. Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. Drug and Alcohol Dependence. 179: 117-123. PMID 28763779 DOI: 10.1016/j.drugalcdep.2017.06.025  1
2017 Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage. Clinical. 15: 812-818. PMID 28725548 DOI: 10.1016/j.nicl.2017.06.003  1
2017 Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28679529 DOI: 10.1096/fj.201601234R  1
2017 Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. QT prolongation by dexamphetamine: Does experience matter? Journal of Cardiovascular Electrophysiology. PMID 28452189 DOI: 10.1111/jce.13235  1
2017 Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging and Behavior. PMID 28290072 DOI: 10.1007/s11682-017-9695-x  0.96
2017 Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. Plos One. 12: e0171724. PMID 28267750 DOI: 10.1371/journal.pone.0171724  0.96
2017 Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, ... ... Reneman L, et al. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. Plos One. 12: e0172776. PMID 28241065 DOI: 10.1371/journal.pone.0172776  1
2016 Karel P, Calabrese F, Riva M, Brivio P, Van der Veen B, Reneman L, Verheij M, Homberg J. d-Cycloserine enhanced extinction of cocaine-induced conditioned place preference is attenuated in serotonin transporter knockout rats. Addiction Biology. PMID 27957784 DOI: 10.1111/adb.12483  0.76
2016 Menning S, de Ruiter MB, Kieffer JM, van Rentergem JA, Veltman DJ, Fruijtier A, Oldenburg HS, Boven E, van der Meij S, Lustig V, Bos ME, Boogerd W, Reneman L, Schagen SB. Cognitive impairment in a subset of breast cancer patients following systemic therapy - results from a longitudinal study. Journal of Pain and Symptom Management. PMID 27650011 DOI: 10.1016/j.jpainsymman.2016.04.012  0.96
2016 Kaag AM, Schluter RS, Karel P, Homberg J, van den Brink W, Reneman L, van Wingen GA. Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum. Frontiers in Human Neuroscience. 10: 418. PMID 27594829 DOI: 10.3389/fnhum.2016.00418  1
2016 Vegting Y, Reneman L, Booij J. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Psychopharmacology. PMID 27568200 DOI: 10.1007/s00213-016-4396-5  1
2016 Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HM, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, ... ... Reneman L, et al. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27487479 DOI: 10.1001/jamapsychiatry.2016.1572  1
2016 Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on cART. Aids (London, England). PMID 27149087 DOI: 10.1097/QAD.0000000000001133  1
2016 Kaag AM, Levar N, Woutersen K, Homberg J, van den Brink W, Reneman L, van Wingen G. Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. The American Journal of Psychiatry. appiajp201615040433. PMID 27079132 DOI: 10.1176/appi.ajp.2016.15040433  1
2016 Tamminga HG, Reneman L, Huizenga HM, Geurts HM. Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis. Psychological Medicine. 1-17. PMID 27019103 DOI: 10.1017/S0033291716000350  0.44
2016 Kaag AM, van Wingen GA, Caan MW, Homberg JR, van den Brink W, Reneman L. White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances. Addiction Biology. PMID 26860848 DOI: 10.1111/adb.12375  1
2015 van Doorn M, Oude Rengerink K, Newsum EA, Reneman L, Majoie CB, Pajkrt E. Added value of fetal MRI in fetuses with suspected brain abnormalities on neurosonography: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-13. PMID 26592136 DOI: 10.3109/14767058.2015.1109621  1
2015 Stouten-Kemperman MM, de Ruiter MB, Caan MW, Boogerd W, Kerst MJ, Reneman L, Schagen SB. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping. PMID 26304182 DOI: 10.1002/hbm.22942  1
2015 Klomp A, Václavů L, Meerhoff GF, Reneman L, Lucassen PJ. Correction: Effects of Chronic Fluoxetine Treatment on Neurogenesis and Tryptophan Hydroxylase Expression in Adolescent and Adult Rats. Plos One. 10: e0135876. PMID 26295703 DOI: 10.1371/journal.pone.0135876  0.88
2015 Crunelle CL, Kaag AM, van den Munkhof HE, Reneman L, Homberg JR, Sabbe B, van den Brink W, van Wingen G. Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. Human Brain Mapping. 36: 4222-30. PMID 26220024 DOI: 10.1002/hbm.22913  1
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls. Brain Imaging and Behavior. PMID 26149196 DOI: 10.1007/s11682-015-9419-z  1
2015 Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB. Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes. Brain Imaging and Behavior. PMID 26063438 DOI: 10.1007/s11682-015-9395-3  0.96
2015 van der Marel K, Bouet V, Meerhoff GF, Freret T, Boulouard M, Dauphin F, Klomp A, Lucassen PJ, Homberg JR, Dijkhuizen RM, Reneman L. Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis. Neuroscience. PMID 25934041 DOI: 10.1016/j.neuroscience.2015.04.044  1
2015 Menning S, de Ruiter MB, Veltman DJ, Koppelmans V, Kirschbaum C, Boogerd W, Reneman L, Schagen SB. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue. Neuroimage. Clinical. 7: 547-54. PMID 25844311 DOI: 10.1016/j.nicl.2015.02.005  1
2015 Bottelier MA, Schouw ML, de Ruiter MB, Ruhe HG, Lindauer RJ, Reneman L. Effects of methylphenidate during emotional processing in amphetamine users: preliminary findings. Brain Imaging and Behavior. PMID 25563230 DOI: 10.1007/s11682-014-9350-8  1
2015 Schrantee A, Václav? L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1172-80. PMID 25394786 DOI: 10.1038/npp.2014.301  1
2015 Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, Boogerd W, Reneman L, Schagen SB. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior. 9: 275-84. PMID 24858488 DOI: 10.1007/s11682-014-9305-0  1
2015 Van Schaik SM, Reneman L, Engelen M, Roos YB, Poll-The BT. Strokelike episodes and cutis marmorata telangiectatica congenita. Journal of Child Neurology. 30: 129-32. PMID 24525998 DOI: 10.1177/0883073813516675  1
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9419-z  1
2015 Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB. Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9395-3  1
2014 Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Veltman DJ, Reneman L, Schagen SB. Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 25529014 DOI: 10.1017/S1355617714001015  1
2014 Kaag AM, Crunelle CL, van Wingen G, Homberg J, van den Brink W, Reneman L. Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. Drug and Alcohol Dependence. 144: 210-7. PMID 25278147 DOI: 10.1016/j.drugalcdep.2014.09.016  1
2014 Klomp A, Hamelink R, Feenstra M, Denys D, Reneman L. Increased response to a 5-HT challenge after discontinuation of chronic serotonin uptake inhibition in the adult and adolescent rat brain. Plos One. 9: e99873. PMID 24937739 DOI: 10.1371/journal.pone.0099873  1
2014 Klomp A, Václav? L, Meerhoff GF, Reneman L, Lucassen PJ. Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats. Plos One. 9: e97603. PMID 24827731 DOI: 10.1371/journal.pone.0097603  1
2014 Schiering IA, de Haan TR, Niermeijer JM, Koelman JH, Majoie CB, Reneman L, Aronica E. Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia. Journal of Neuropathology and Experimental Neurology. 73: 324-34. PMID 24607964 DOI: 10.1097/NEN.0000000000000056  1
2014 Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. Bmc Psychiatry. 14: 48. PMID 24552282 DOI: 10.1186/1471-244X-14-48  1
2014 Crunelle CL, Kaag AM, van Wingen G, van den Munkhof HE, Homberg JR, Reneman L, van den Brink W. Reduced frontal brain volume in non-treatment-seeking cocaine-dependent individuals: exploring the role of impulsivity, depression, and smoking. Frontiers in Human Neuroscience. 8: 7. PMID 24478673 DOI: 10.3389/fnhum.2014.00007  1
2014 van der Marel K, Klomp A, Meerhoff GF, Schipper P, Lucassen PJ, Homberg JR, Dijkhuizen RM, Reneman L. Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 263-73. PMID 23851400 DOI: 10.1038/npp.2013.169  1
2014 Schrantee A, Reneman L. Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity. Neuropharmacology. 84: 159-69. PMID 23851258 DOI: 10.1016/j.neuropharm.2013.06.029  1
2013 van Arnhem LA, Bunders MJ, Scherpbier HJ, Majoie CB, Reneman L, Frinking O, Poll-The BT, Kuijpers TW, Pajkrt D. Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy. Plos One. 8: e64398. PMID 23691211 DOI: 10.1371/journal.pone.0064398  1
2013 Klomp A, van Wingen GA, de Ruiter MB, Caan MW, Denys D, Reneman L. Test-retest reliability of task-related pharmacological MRI with a single-dose oral citalopram challenge. Neuroimage. 75: 108-16. PMID 23501048 DOI: 10.1016/j.neuroimage.2013.03.002  1
2013 Schouw ML, Caan MW, Geurts HM, Schmand B, Booij J, Nederveen AJ, Reneman L. Monoaminergic dysfunction in recreational users of dexamphetamine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1491-502. PMID 23415394 DOI: 10.1016/j.euroneuro.2013.01.005  1
2013 Schouw ML, Kaag AM, Caan MW, Heijtel DF, Majoie CB, Nederveen AJ, Booij J, Reneman L. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI. Neuroimage. 72: 1-9. PMID 23296186 DOI: 10.1016/j.neuroimage.2012.12.056  1
2013 Booij J, Reneman L, Alders M, Kuijpers TW. Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotype. American Journal of Medical Genetics. Part A. 161: 102-7. PMID 23239620 DOI: 10.1002/ajmg.a.35687  1
2013 Schouw ML, De Ruiter MB, Kaag AM, van den Brink W, Lindauer RJ, Reneman L. Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. Drug and Alcohol Dependence. 130: 52-60. PMID 23142493 DOI: 10.1016/j.drugalcdep.2012.10.010  1
2013 Van Wezel EM, Van Santen HM, Van Furth WR, Reneman L, Bisschop PH, Paul Van Trotsenburg AS. Children with obesity and declining linear growth curve: Cushings disease? | Kinderen met obesitas en afbuigende lengtegroeicurve: Ziekte van Cushing? Nederlands Tijdschrift Voor Geneeskunde. 157.  1
2012 van Wezel EM, van Santen HM, van Furth W, Reneman L, Bisschop PH, van Trotsenburg AS. [Children with obesity and declining linear growth curve: Cushing's disease?]. Nederlands Tijdschrift Voor Geneeskunde. 156: A4677. PMID 23249505  1
2012 Klomp A, den Hollander B, de Bruin K, Booij J, Reneman L. The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals. Plos One. 7: e47524. PMID 23115651 DOI: 10.1371/journal.pone.0047524  1
2012 Klomp A, Caan MW, Denys D, Nederveen AJ, Reneman L. Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function. Neuroimage. 63: 1695-700. PMID 22842212 DOI: 10.1016/j.neuroimage.2012.07.038  1
2012 Reneman L, de Win MM, Booij J, van den Brink W, den Heeten GJ, Freling N, Majoie CB. Incidental head and neck findings on MRI in young healthy volunteers: prevalence and clinical implications. Ajnr. American Journal of Neuroradiology. 33: 1971-4. PMID 22723061 DOI: 10.3174/ajnr.A3217  1
2012 Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L. The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. Journal of Visualized Experiments : Jove. PMID 22565099 DOI: 10.3791/3956  1
2012 Schouw ML, Gevers S, Caan MW, Majoie CB, Booij J, Nederveen AJ, Reneman L. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 537-45. PMID 22209360 DOI: 10.1016/j.euroneuro.2011.12.002  1
2012 Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L. Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology. 221: 329-39. PMID 22205158 DOI: 10.1007/s00213-011-2580-1  1
2012 de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Human Brain Mapping. 33: 2971-83. PMID 22095746 DOI: 10.1002/hbm.21422  1
2012 Klomp A, Tremoleda JL, Wylezinska M, Nederveen AJ, Feenstra M, Gsell W, Reneman L. Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI. Neuroimage. 59: 218-26. PMID 21840402 DOI: 10.1016/j.neuroimage.2011.07.082  1
2012 den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L. Preliminary evidence of hippocampal damage in chronic users of ecstasy. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 83-5. PMID 21444322 DOI: 10.1136/jnnp.2010.228387  1
2011 Harsay HA, Cohen MX, Reneman L, Ridderinkhof KR. How the aging brain translates motivational incentive into action: the role of individual differences in striato-cortical white matter pathways. Developmental Cognitive Neuroscience. 1: 530-9. PMID 22436569 DOI: 10.1016/j.dcn.2011.06.005  1
2011 Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P, Korte-Bouws G, van Luijtelaar G, Reneman L. Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. Plos One. 6: e16646. PMID 21304948 DOI: 10.1371/journal.pone.0016646  1
2011 de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, Boven E, Schagen SB. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping. 32: 1206-19. PMID 20669165 DOI: 10.1002/hbm.21102  1
2009 Aukema EJ, Caan MW, Oudhuis N, Majoie CB, Vos FM, Reneman L, Last BF, Grootenhuis MA, Schouten-van Meeteren AY. White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. International Journal of Radiation Oncology, Biology, Physics. 74: 837-43. PMID 19117694 DOI: 10.1016/j.ijrobp.2008.08.060  1
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain : a Journal of Neurology. 131: 2936-45. PMID 18842607 DOI: 10.1093/brain/awn255  1
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W. Neurotoxic effects of ecstasy on the thalamus. The British Journal of Psychiatry : the Journal of Mental Science. 193: 289-96. PMID 18827290 DOI: 10.1192/bjp.bp.106.035089  1
2008 Visser I, Lavini C, Booij J, Reneman L, Majoie C, de Boer AG, Wekking EM, de Joode EA, van der Laan G, van Dijk FJ, Schene AH, Den Heeten GJ. Cerebral impairment in chronic solvent-induced encephalopathy. Annals of Neurology. 63: 572-80. PMID 18412121 DOI: 10.1002/ana.21364  1
2007 de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 458-70. PMID 17077812 DOI: 10.1038/sj.npp.1301225  1
2006 Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology (Oxford, England). 20: 389-99. PMID 16574713 DOI: 10.1177/0269881106063266  1
2006 de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology (Oxford, England). 20: 226-35. PMID 16510480 DOI: 10.1177/0269881106063275  1
2006 Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology (Oxford, England). 20: 164-75. PMID 16510475 DOI: 10.1177/0269881106061515  1
2005 De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research. 14: 167-85. PMID 16395871 DOI: 10.1002/mpr.6  1
2005 de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 996-1005. PMID 15770240 DOI: 10.1038/sj.npp.1300683  1
2004 de Win MM, de Jeu RA, de Bruin K, Habraken JB, Reneman L, Booij J, den Heeten GJ. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 185-9. PMID 15056477 DOI: 10.1016/S0924-977X(03)00101-9  1
2004 de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology. 173: 376-82. PMID 14726997 DOI: 10.1007/s00213-003-1723-4  1
2002 Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse (New York, N.Y.). 46: 199-205. PMID 12325046 DOI: 10.1002/syn.10130  1
2002 Haddad PM, Strickland P, Anderson I, Deakin JFW, Dursun SM, Ratzenböck E, Reneman L, Booij J, Den Heeten GJ, Van Den Brink W. Effects of MDMA (ecstasy) use and abstention on serotonin neurons [1] (multiple letters) Lancet. 359: 1616-1618. PMID 12047988  1
2002 Hurley RA, Reneman L, Taber KH. Ecstasy in the brain: a model for neuroimaging. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 125-9. PMID 11983786 DOI: 10.1176/appi.neuropsych.14.2.125  1
2002 Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Psychopharmacology. 159: 335-40. PMID 11862367 DOI: 10.1007/s00213-001-0930-0  1
2002 Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 387-96. PMID 11850153 DOI: 10.1016/S0893-133X(01)00366-9  1
2002 Reneman L, Majoie CB, Flick H, den Heeten GJ. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results. Ajnr. American Journal of Neuroradiology. 23: 231-7. PMID 11847047  1
2002 Reneman L, Booij J, Schmand B, Reitsma JB, De Wolff FA, Gunning WB, Den Heeten GJ, Van Den Brink W. Short- and long-term effects of ecstasy on serotonin-producing cells in the brain and on memory | Korte- en langetermijneffecten van ecstasy op serotonineproducerende hersencellen en het geheugen Nederlands Tijdschrift Voor Geneeskunde. 146: 2240-2246.  1
2001 Reneman L, Booij J, Majoie CB, Van Den Brink W, Den Heeten GJ. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. Human Psychopharmacology. 16: 579-588. PMID 12404537 DOI: 10.1002/hup.347  1
2001 Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 358: 1864-9. PMID 11741626 DOI: 10.1016/S0140-6736(01)06888-X  1
2001 Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biological Psychiatry. 50: 550-4. PMID 11600108 DOI: 10.1016/S0006-3223(01)01177-5  1
2001 Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Archives of General Psychiatry. 58: 901-6. PMID 11576026  1
2001 Reneman L, Majoie CB, Habraken JB, den Heeten GJ. Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology. 220: 611-7. PMID 11526257 DOI: 10.1148/radiol.2202001602  1
2001 Lavalaye J, Booij J, Linszen DH, Reneman L, van Royen EA. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. Psychopharmacology. 156: 53-7. PMID 11465633 DOI: 10.1007/s002130000679  1
2001 Lavalaye J, Sarlet A, Booij J, Linszen DH, Reneman L, Gersons BP, van Royen EA. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology. 155: 107-9. PMID 11374328 DOI: 10.1007/s002130000670  1
2001 Reneman L, De Bruin K, Lavalaye J, Gunning WB, Booij J. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse (New York, N.Y.). 39: 193-200. PMID 11169768 DOI: 10.1002/1098-2396(20010301)39:3<193::AID-SYN1000>3.0.CO;2-F  1
2001 Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken JB, Gersons BP, van Royen EA. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. Schizophrenia Research. 47: 59-67. PMID 11163545 DOI: 10.1016/S0920-9964(00)00023-2  1
2001 Booij J, Reneman L, Lavalaye J, Knol RJJ, De Bruin K, Speelman JD, Janssen AGM. Dopamine transporter imaging as an in vivo marker of dopaminergic neurons Drugs of the Future. 26: 271-279. DOI: 10.1358/dof.2001.026.03.858707  1
2000 Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. European Journal of Nuclear Medicine. 27: 867-9. PMID 10952500  1
2000 Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. Ajnr. American Journal of Neuroradiology. 21: 1001-7. PMID 10871002  1
2000 Lavalaye J, Knol RJ, de Bruin K, Reneman L, Janssen AG, Booij J. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication. European Journal of Nuclear Medicine. 27: 346-9. PMID 10774889  1
2000 Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology. 148: 322-4. PMID 10755746  1
1999 Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. Psychiatry Research. 92: 33-44. PMID 10688158 DOI: 10.1016/S0925-4927(99)00032-3  1
1999 Reneman L, Booij J, Lavalaye J, De Bruin K, De Wolff FA, Koopmans RP, Stoof JC, Den Heeten GJ. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain. Synapse (New York, N.Y.). 34: 77-80. PMID 10459174 DOI: 10.1002/(SICI)1098-2396(199910)34:1<77::AID-SYN9>3.0.CO;2-Y  1
1998 Booij J, Knol RJ, Reneman L, de Bruin K, Janssen AG, van Royen EA. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats. European Journal of Nuclear Medicine. 25: 1666-9. PMID 9871099 DOI: 10.1007/s002590050346  1
1997 Reneman L, Derwig J. Long-term prospects of malnourished children after rehabilitation at the Nutrition Rehabilitation Centre of St Mary's Hospital, Mumias, Kenya. Journal of Tropical Pediatrics. 43: 293-6. PMID 9364128  1
Show low-probability matches.